Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats. [electronic resource]
Producer: 20171006Description: e6665 p. digitalISSN:- 1414-431X
- Alanine Transaminase -- blood
- Ammonia -- blood
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Animals
- Benzimidazoles -- pharmacology
- Biphenyl Compounds
- Disease Models, Animal
- End Stage Liver Disease -- complications
- Enzyme-Linked Immunosorbent Assay
- Glutathione -- analysis
- Liver -- drug effects
- Liver Cirrhosis -- complications
- Locomotion -- physiology
- Losartan -- pharmacology
- Male
- Malondialdehyde -- analysis
- Motor Disorders -- drug therapy
- Random Allocation
- Rats, Sprague-Dawley
- Reproducibility of Results
- Reverse Transcriptase Polymerase Chain Reaction
- Tetrazoles -- pharmacology
- Thioacetamide
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- blood
- gamma-Glutamyltransferase -- blood
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.